J&J Hit With $8 Billion Jury Award Over Antipsychotic Drug

A Philadelphia jury on Tuesday ordered Johnson & Johnson [US:JNJ] to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://www.wsj.com/articles/j-j-hit-with-8-billion-jury-award-over-antipsychotic-drug-11570577281